See What HealthDay Can Do For You
Contact Us

Follow-Up Phone Calls May Boost Glycemic Control in T2DM

No statistically significant change in hemoglobin A1c, but clinically significant change observed

elderly woman on cell phone

FRIDAY, Nov. 18, 2016 (HealthDay News) -- For patients with type 2 diabetes, follow-up phone calls after a monthly clinic visit could lead to clinically significant change in hemoglobin A1C (HbA1c) levels, according to a study published online Nov. 13 in the Journal of Clinical Nursing.

Cheryl Brown-Deacon, D.N.P., from the University of Michigan-Flint, and colleagues conducted a quality improvement study to examine the effectiveness of follow-up phone calls in improving frequency of glucose monitoring over a three-month period in patients with type 2 diabetes. A total of 41 patients with type 2 diabetes with HbA1c ≥7.5 percent were included in the study. Over a three-month period, patients were assigned to receive standard care (Group 1) or to receive standard care plus follow-up phone calls within two weeks after a monthly clinic visit (Group 2).

The researchers observed no statistically significant between-group differences in the baseline HbA1c or the three-month HbA1c. The mean HbA1c change did not differ significantly between Groups 1 and 2. There were no statistically significant differences between the groups in the number of patients who kept logs of their blood glucose readings.

"The intervention using telephone follow-up calls did not show a statistically significant improvement in overall HbA1c, but there was a clinically significant change in HbA1c in the group of patients that received follow-up phone calls," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing
undefined
undefinedundefined